Teneliximab
Modify Date: 2025-08-26 11:18:25
Teneliximab structure
|
Common Name | Teneliximab | ||
|---|---|---|---|---|
| CAS Number | 299423-37-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TeneliximabTeneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion[1]. |
| Name | Teneliximab |
|---|
| Description | Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Teneliximab (Chi220, BMS-224819) 的作用不仅仅是通过清除CD20承载细胞介导的，联合治疗没有显著损害已建立的抗病毒免疫[2]。 |
| References |
| No Any Chemical & Physical Properties |